Overview

Evaluation of the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder

Status:
NOT_YET_RECRUITING

Trial end date:
2026-07-31

Target enrollment:

Participant gender:

Summary

Evaluation of the efficacy in increasing sexual arousal, safety and tolerability of BZ371A in gel form applied to women with sexual arousal disorder

Phase:

PHASE2

Details

Lead Sponsor:

Biozeus Biopharmaceutical S.A.